A Discernment and Apostasy watch site for African Saints.
Prove all things..(1 Thesa.5:21)
Test Spirits..(I John 4:1)
Like the Bereans, check whether things are so(Acts 17:11)
KAMPALA — International televangelists Benny Hinn and Kenneth Copeland
are facing a social media backlash in Uganda after postponing their
planned healing crusades over Ebola concerns, with many questioning why
preachers known for claiming miraculous healings would avoid a country
battling an outbreak.
The Global Conference on the Holy Spirit, scheduled for June 27-29 at
Miracle Centre Cathedral in Kampala and hosted by Pastor Robert
Kayanja, was expected to draw thousands of worshippers and also feature
Nigerian preacher Paul Enenche.
Organisers said the event was postponed following consultations
with health experts over the Ebola situation and risks associated with
large gatherings.
The decision, however, sparked sharp reactions online.
“The healer? Please sir come and heal us from this Ebola,” one user posted on X.
Another, Isaac Mulindwa, wrote: “They do not trust the very faith they preach.”
A third user remarked: “You mean the guys who can heal through
faith have no ability to fight the Ebola virus through faith? I’m
shocked.”
The criticism reflects a broader debate over faith healing, with some
Ugandans arguing that an Ebola outbreak would have been an opportunity
for the televangelists to demonstrate the miraculous powers they preach
about rather than a reason to stay away.
Supporters of the postponement, however, defended the move as a
prudent public health decision, noting that Uganda has previously
contained Ebola outbreaks through strict measures, including limiting
mass gatherings.
Organisers say the conference is likely to be rescheduled later
this year, but for many online critics, the cancellation has raised
uncomfortable questions about the limits of faith healing in the face of
a deadly disease.
Wickedness in high places : When Ebola creators pretend to be
messianic solvers on their own biological weapon : WHO meets on experimental
Ebola drug use
Ebola as a US neo-imperialistic weapon: Portray Africans as poor
helpless zombies: Come in as a solution to the Ebola virus you have created :
Use this pretext to steal their mineral resources : Obama: Ebola crisis
'spiraling out of control' : US military to help Ebola effort
ESAU(WHITEMAN), YOU ARE VERY WICKED: EVEN THE MOST HIGH CALLS YOU
WICKED: WHY DO YOU MANUFACTURE VIRUSES TO KILL JACOB( THE BANTU): 131 dead in
Ebola outbreak in DR Congo
BIO-WARFARE: WHO and the US Military succeed in making the Ebola
virus a sexually transmitted disease like HIV: Ebola virus found Liberian Man’s
semen 175 days after he was declared Ebola free
health care, received the vials on behalf of the government and described the donation as a critical safeguard for Ugandan families.
Although Uganda currently has no active
Ebola cases, an ongoing outbreak of the Bundibugyo species in
neighbouring Democratic Republic of Congo (DRC) poses a serious and
immediate health security risk.
According to US officials, the DRC
outbreak had grown into the largest recorded outbreak of Ebola outside
West Africa, with more than 4,500 confirmed cases and over 2,000 deaths
as of mid-August 2026.
“This donation reflects our commitment to
Uganda’s health security, because a safer Uganda means a safer world. By
helping Uganda act within hours rather than days, the United States is
also protecting Americans. An outbreak anywhere is a threat everywhere,”
US Chargé d’Affaires Mikael Cleverley said.
How MBP134 works
MBP134 was developed by Mapp
Biopharmaceutical under a contract with the Biomedical Advanced Research
and Development Authority (BARDA), an agency within the US Department
of Health and Human Services.
The antibody is designed to act faster
than the body’s natural immune response by recognising and neutralising
the Ebola virus rather than waiting for the body to develop its own
immunity over days or weeks.
Pre-clinical studies have shown MBP134 to
be effective against multiple Ebola species, including the Bundibugyo
species responsible for the current outbreak in the DRC.
For a disease with limited treatment options, the antibody offers an additional tool for doctors responding to suspected cases.
MBP134 is not commercially available and
is being provided for compassionate use, allowing doctors to administer
it to critically ill patients while research into its effectiveness
continues.
Regional response
The donation is part of broader US efforts
to strengthen Ebola preparedness and response in the region. The United
States has announced more than $619 million in funding to countries in
the region to support Ebola response activities, including preparedness,
surveillance and outbreak control.
